Evidence map›Paper›PMID 26142551›Full record

ArticleGastrointestinal endoscopy2016

Unsedated transnasal esophagoscopy for monitoring therapy in pediatric eosinophilic esophagitis.

Joel A Friedlander, Emily M DeBoer, Jason S Soden, Glenn T Furuta, Calies D Menard-Katcher, Dan Atkins, David M Fleischer, Robert E Kramer, Robin R Deterding, Kelley E Capocelli and 1 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Gastrointestinal endoscopy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04149470 phase4unknown statusnot on this mapstarted 2020, after this paper: background citation

Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)

TypeinterventionalSponsorUniversity of Colorado, DenverRan2020 to 2024Enrolled90ConditionsEosinophilic EsophagitisArmsOmeprazole 20mg BID
NCT06200961 narecruitingnot on this mapstarted 2026, after this paper: background citation

Use of Sedation-Free Transnasal Endoscopy to Improve Access and Lower Costs of Endoscopic Evaluations in a Bariatric Medical and Surgical Program

TypeinterventionalSponsorChristopher C. Thompson, MD, MScRan2026 to 2028Enrolled100ConditionsObesity, Obesity, Morbid, Obese, GI DisordersArmsTransnasal Endoscopy, Esophagogastroduodenoscopy
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Guideline
  2. Shifting the scope: Moving toward less invasive diagnosis and monitoring of eosinophilic esophagitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Review
  3. Anesthesia-free transoral endoscopy using a novel modified pacifier in early infancy.Journal of pediatric gastroenterology and nutrition · 2026
    Article
  4. Article
  5. Eosinophilic gastrointestinal diseases.Nature reviews. Disease primers · 2026
    Review
  6. Article
  7. Review
  8. Emerging Tissue and Blood Biomarkers for Eosinophilic Esophagitis.Gastroenterology clinics of North America · 2026
    Review
  9. Review
  10. Review
  11. Economic Benefit of Implementation of Pediatric Transnasal Endoscopy in Eosinophilic Esophagitis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
    Article
  12. Eosinophilic Esophagitis: Emerging Insights Into Diagnosis and Management.The Korean journal of helicobacter and upper gastrointestinal research · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Joel A FriedlanderDigestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA; Aerodigestive Program, Children's Hospital Colorado, Aurora, Colorado, USA.
Emily M DeBoerAerodigestive Program, Children's Hospital Colorado, Aurora, Colorado, USA; Breathing Institute, Children's Hospital Colorado, Section of Pulmonary Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Jason S SodenDigestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA; Aerodigestive Program, Children's Hospital Colorado, Aurora, Colorado, USA.
Glenn T FurutaDigestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA; Gastrointestinal Eosinophilic Diseases Program, Children's Hospital of Colorado, Aurora, Colorado, USA.
Calies D Menard-KatcherDigestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA; Gastrointestinal Eosinophilic Diseases Program, Children's Hospital of Colorado, Aurora, Colorado, USA.
Dan AtkinsGastrointestinal Eosinophilic Diseases Program, Children's Hospital of Colorado, Aurora, Colorado, USA; Allergy Section, Children's Hospital Colorado, Section of Allergy, Immunology, and Rheumatology, University of Colorado School of Medicine, Aurora, Colorado, USA.
David M FleischerGastrointestinal Eosinophilic Diseases Program, Children's Hospital of Colorado, Aurora, Colorado, USA; Allergy Section, Children's Hospital Colorado, Section of Allergy, Immunology, and Rheumatology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Robert E KramerDigestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA.
Robin R DeterdingAerodigestive Program, Children's Hospital Colorado, Aurora, Colorado, USA; Breathing Institute, Children's Hospital Colorado, Section of Pulmonary Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Kelley E CapocelliDivision of Pediatric Pathology, Children's Hospital of Colorado, Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Jeremy D PragerAerodigestive Program, Children's Hospital Colorado, Aurora, Colorado, USA; Department of Otolaryngology, Children's Hospital Colorado, Department of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Children's Hospital Colorado · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Colorado Clinical and Translational Sciences InstituteKL2TR001080 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$2.6M
Patient research in eosinophilic gastrointestinal diseasesK24DK100303 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI FURUTA, GLENN T · 2013 to 2017
$889k
NCATS NIH HHS KL2 TR001080NCATS NIH HHS UL1 TR001082NIDDK NIH HHS K24 DK100303
6 · The paper itself

Abstract

BACKGROUND AND

aimsUnsedated transnasal endoscopy (TNE) is safer and less costly than sedated EGD. The aim of this study was to evaluate the performance of TNE with biopsies in monitoring the esophageal mucosa of pediatric patients with eosinophilic esophagitis.

methodsPatients between 8 and 17 years of age with eosinophilic esophagitis and their parents were enrolled. Unsedated TNE was performed. A 2.8-mm (1.2-mm channel) or a 4-mm flexible bronchoscope (2-mm channel) was used, and esophageal biopsy specimens were obtained. Biopsy specimen analysis, duration, adverse events, and billing charges of TNE were assessed. Immediately after TNE and a minimum of 2 weeks later, a modified Group Health Association of America 9 survey and a preference questionnaire were completed, respectively.

resultsTwenty-one of 22 enrolled patients underwent TNE. TNE was performed with no serious adverse events. Histopathological analysis revealed 0 eosinophils per high-power field (n = 12), fewer than 15 eosinophils per high-power field (n = 4), and more than 15 eosinophils per high-power field (n = 5). The total epithelial surface area of mucosal biopsy samples from either TNE Forceps (1.2 mm or 2 mm biopsy channel forceps) compared with those obtained during the subject's previous EGD by using standard endoscopic forceps was not statistically different (P = .308 [1.2 mm]/P = .492 [2 mm]). All parents and 76.2% of subjects would undergo the TNE again. TNE was preferred over EGD by 85.7% of parents and 52.4% of subjects. The modified Group Health Association of America 9 survey revealed a high degree of satisfaction (average, 43.19 ± 2.6; maximum score, 45). Charges associated with TNE were 60.1% lower than for previous EGDs.

conclusionsUnsedated TNE is an effective, lower-cost procedure for monitoring the esophageal mucosa of children with eosinophilic esophagitis.

Indexed as

Patient SatisfactionAdolescentBiopsyChildEosinophilic EsophagitisEsophagoscopyFemaleHumansIntestinal MucosaMaleMouthNatural Orifice Endoscopic Surgery

Identifiers

PMID26142551
PMCPMC4698253
OpenAlexW815671507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.